KLK5 and breast cancer: Oncomine analysis of data derived from microarray-based gene expression profiling studies employing established patient datasets [13-15] showed that KLK5 expression is significantly down-regulated or completely inactivated in the majority of breast cancers of different subtypes compared to normal tissues (Fig.1A).